Unregulated Genetic Testing Websites Still Causing Concerns
Though 23andMe finally got FDA approval for a test, that is much different than the unvalidated claims about 250 conditions that they used to make. They got a cease and desist letter from the FDA because of their high profile.
In general, smaller companies are even more aggressive in their marketing claims -they overemphasize their purported benefits and downplay their limitations, including genetic tests whose value for guiding cancer treatment has not been shown to be clinically useful.
"We wanted to see if consumers are getting a balanced picture of benefits and limitations of these…